| abstract |
The present disclosure generally relates to the field of enteral and parenteral nutritional formulations in which enantiomerically-enriched energy substrates are used for providing high caloric density and low osmolarity. In particular monoisomeric glyceryl tri(chiral alkanoates), anomeric mixtures of alpha, beta-D-glucopyranosyl alkanoates, monoisomeric chiral alkanoic acid esters, anomeric chiral alkanoic acid esters as well as methods for their preparation and their use in enteral or parenteral nutrition, for metabolic disorder, trauma and malnutrition are described. |